Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Valentia Biopharma

Valentia Biopharma
Out of Business LATEST DEAL TYPE

Provider of a novel drug discovery platform designed to generate a broad pipeline of first-in-class drugs. The company's novel drug discovery platform analyzes thousands of compounds and have a capacity to reproduce the process of massive molecule testing in vivo using Drosophila individuals enabling the development of additional drugs to treat human diseases.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Parc Científic de la Universitat de València
  • C/Catedrático José Beltrán, 2
  • 46980 Valencia
  • Spain

+34 963 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Valentia Biopharma’s full profile, request a free trial.

Valentia Biopharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Feb-2016 Completed Out of Business
1. Early Stage VC 26-Jun-2008 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Valentia Biopharma Executive Team (2)

Name Title Board
Rebeca Lucas Co-Founder & Chief Executive Officer
Manuel Perez-Alonso Ph.D Co-Founder & Scientific Director